Sight Sciences Insider Sales As Quarterly Loss Exceeds Estimates.

Sight Sciences, Inc. (NASDAQ: SGHT) reported a quarterly earnings loss of $0.25 per share, exceeding estimates, with revenues of $21.37 million. On October 1, insider Jeremy B. Hayden sold 4,878 shares for $29,658.24, while CFO Alison Bauerlein sold 10,130 shares. The company, specializing in ophthalmic medical devices, has a market cap of $298.54 million and is rated "Hold" by analysts, with a target price of $7.25.